oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of alzheimer disease氧化应激诱导的线粒体失败和血管灌注不足的主要发起者阿尔茨海默病的发展.pdfVIP
- 1、本文档共30页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of alzheimer disease氧化应激诱导的线粒体失败和血管灌注不足的主要发起者阿尔茨海默病的发展
Pharmaceuticals 2010, 3, 158-187; doi:10.3390/ph3010158
OPEN ACCESS
Pharmaceuticals
ISSN 1424–8247
/journal/pharmaceuticals
Review
Oxidative Stress Induced Mitochondrial Failure and Vascular
Hypoperfusion as a Key Initiator for the Development of
Alzheimer Disease
Gjumrakch Aliev 1,2,3,*, Hector H. Palacios 4, Eldar Gasimov 5, Mark E. Obrenovich 6,
Ludis Morales 2, Jerzy Leszek 7, Valentin Bragin 3, Arturo Solís Herrera 8 and
9
Dmitry Gokhman
1 School of Health Science and Healthcare Administration, University of Atlanta, 6685 Peachtree
Industrial Blvd., Atlanta, Georgia, 30360, USA
2 Department of Nutrition and Biochemistry, Faculty of Sciences, Javeriana University, Bogotà D.C.,
Colombia
3 Stress Relief and Memory Training Center, Brooklyn, New York, NY 11235, USA
4 Department of Biology, College of Sciences, University of Texas at San Antonio, One UTSA
Circle, San Antonio, TX 78249– 1664, USA
5 Department of Cytology, Histology and Embryology, Azerbaijan Medical University, 25 Street
Bakhikhanov, Baku AZ10 25, Azerbaijan
6 Department of Pathology, School of Medicine, Case Western Reserve University, WRB 5301,
Cleveland, Ohio, 44106, USA
7 Department of Psychiatry, Wroclaw Medical University, 25 St. Kraszewskiego, Wroclaw, 50–229,
Poland
8 Dirección de Investigación y desarrollo, Centro de Estudios de la Fotosíntesis Humana, S.C. López
Velarde 108 y 109, Centro, Aguascalientes, Aguascalientes, 20000, México
9 Department of Mathematics, College of Sciences, University of Texas at San Antonio, One UTSA
Circle, San Antonio, TX 78249, USA
* Author to whom correspondence
您可能关注的文档
- o-quinonoid heterocycles synthesis and crystal structure of 2,3-dicyano-5,7-bismethylthieno[3,4-b]pyrazineo-quinonoid杂环化合物的合成及晶体结构的3-dicyano-5,7-bismethylthieno[3、4 b]吡嗪.pdf
- optoelectronic plethysmography has improved our knowledge of respiratory physiology and pathophysiology光电容积描记术提高了我们呼吸生理学和病理生理学的知识.pdf
- oral administration of shark type ii collagen suppresses complete freund’s adjuvant-induced rheumatoid arthritis in rats口服的鲨鱼ii型胶原蛋白抑制完全弗氏adjuvant-induced风湿性关节炎大鼠.pdf
- oral and dental health care practices in pregnant women in australia a postnatal survey口腔和牙齿健康护理实践在澳大利亚孕妇产后调查.pdf
- optoelectronic capillary sensors in microfluidic and point-of-care instrumentation光电毛细管传感器在微流控和医疗点仪器.pdf
- optimizing urban material flows and waste streams in urban development through principles of zero waste and sustainable consumption优化城市物质流和废物流在城市发展u201c零浪费u201d的原则和可持续消费.pdf
- optimum family size for progeny testing in populations with different strains最佳家庭规模为后代测试人群中有不同的菌株.pdf
- oral cleft prevention program (ocpp)口服裂预防计划(ocpp).pdf
- oral hypoglycemic drugs pathophysiological basis of their mechanism of actionoral hypoglycemic drugs pathophysiological basis of their mechanism of action病理生理机制的基础上口服降糖药物actionoral降糖药物作用机理的病理生理基础.pdf
- optimum conductive fabric sensor sites for evaluating the status of knee joint movements using bio-impedance优化导电织物传感器网站使用阻抗评价膝关节运动的状态.pdf
最近下载
- 美国fda生产过程(工艺)验证总则指南中英文版.doc VIP
- 成都理工大学2020-2021学年第2学期《环境监测》期末考试试卷及标准答案.docx
- 2024年江苏省无锡市中考英语真题卷(含答案与解析).docx VIP
- 年产水性油墨、凹版塑料环保油墨4500 吨、水性涂料500吨建设项目环评(2021年新版环评)环境影响报告表.pdf VIP
- fda美国食品药物管理局工艺验证指南英文版).doc VIP
- 金属非金属露天矿山建设项目安全设施竣工验收表.pdf VIP
- 单位员工网络安全培训.pptx VIP
- PQE试用期述职报告.pptx VIP
- 《GBT 30130-2023胶版印刷纸》最新解读.pptx
- GJB9001C:2017研发一整套资料模板(共348页).pdf VIP
文档评论(0)